Genetically Engineered T Cells Used as a Weapon Against HIV/AIDS

U. Penn researchers have published promising results from what they claim is the first clinical trial of a genetic approach to fighting HIV/AIDS. Doctors removed HIV-positive patients' T cells and genetically modified a portion of them to include a rare HIV-resistant genetic mutation before reintroducing the cells.